The incoming Biden administration announces plans to rapidly release most available vaccine doses against coronavirus disease 2019; the Trump administration approves the first Medicaid block grant in Tennessee; pharmaceutical executives and trade groups condemn last week’s pro-Trump riots on Capitol Hill.
According to the Associated Press, the office of President-elect Joe Biden announced plans this past Friday to rapidly release most available vaccine doses to protect more Americans against coronavirus disease 2019 (COVID-19)—marking a reversal of current Trump administration policies. Biden’s plan would accelerate the shipment of first doses and use federal power to avoid any lag delaying the required second dose. A recent analysis published in the Annals of Internal Medicine finds that, if a steady supply of vaccine were maintained, a flexible approach analogous to Biden’s may prevent an additional 23% to 29% of COVID-19 cases compared with the current fixed strategy.
Kaiser Health News reports that the Trump administration will allow, in a first-of-its-kind move, for Tennessee officials to restrict medications covered by the state Medicaid program and to maintain a closed formulary, similar to the approach taken by private health plans. The approval of the novel Medicaid financing system serves as a 10-year experiment, in which the state will get an annual block grant instead of federal funding that would rise with higher enrollment and health costs. Tennessee’s state Medicaid program, TennCare, said the block grant system would provide unprecedented flexibility to determine who is covered and what services it will pay for.
As reported by FiercePharma, pharmaceutical executives and trade groups condemned pro-Trump riots that occurred on Capitol Hill last week, with some industry representatives supporting calls to consider impeaching President Donald Trump. The National Association of Manufacturers, which includes representatives from Pfizer, Johnson & Johnson, and Eli Lilly, labeled the riots as sedition and blamed Trump for inciting violence, which they say should warrant consideration of invoking the 25th Amendment to remove him from office.
Navigating Medicare's Part D Subsidy Program to Achieve Value-Based Care
May 26th 2023On this episode of Managed Care Cast, we speak with the lead researcher from a study published in the May 2023 issue of The American Journal of Managed Care® about the impact of low-income subsidies on the uptake and equitable use of expensive orally administered antimyeloma therapy.
Listen
AHN’s Center for Inclusion Health Personalizing Equitable Care Delivery for Marginalized Communities
February 28th 2023On this episode of Managed Care Cast, we speak with Elizabeth Cuevas, MD, division chief of Allegheny Health Network’s (AHN) Center for Inclusion Health, on prevalent health inequities facing marginalized communities and strategies to identify and address these issues.
Listen
Health Equity Adjustments in Medicare HVBP Program Will Benefit Safety Net Hospitals, Study Says
March 29th 2024Medicare’s upcoming health equity adjustment in the Hospital Value-Based Purchasing (HVBP) program will reduce disproportionate penalization among safety net hospitals and those serving high proportions of Black patients, according to a recent study.
Read More
Dr Al Benson on Reimbursement for Supportive Care When Treating Patients With Cancer
March 22nd 2024Al Benson, MD, FACP, FACCC, FASCO, medical oncologist at Northwestern University Feinberg School of Medicine and associate director of the Robert E. Tillery Comprehensive Cancer Center, discussed findings from a national survey assessing barriers to comprehensive cancer care delivery.
Read More